This prolonged residence in the stomach can lead to severe nausea, vomiting, heartburn, and abdominal discomfort
Why Weight-Loss Medications Are Often Harder to Cover One reason coverage varies widely is that obesity treatment has historically been treated differently from other chronic conditions
(Conference abstract reporting NA-931s efficacy in DIO mice: ~26% weight reduction, improved lipids, no muscle loss or serious adverse effects) (NA-931, a novel quadruple IGF-1, GLP-1 and GIP incretin receptor agonist reduces body weight without muscle loss | Obesity Conferences 2024 | Weight Management Conferences 2024 | Obesity Events 2024 | Weight Management Congress | Obesity Conference) (NA-931, a novel quadruple IGF-1, GLP-1 and GIP incretin receptor agonist reduces body weight without muscle loss | Obesity Conferences 2024 | Weight Management Conferences 2024 | Obesity Events 2024 | Weight Management Congress | Obesity Conference)
Therefore, when blood glucose is high, insulin secretion is stimulated and Glc secretion is inhibited
You should focus on identifying patterns, monitoring your dosage, and seeking professional advice when needed